Alice Marie Stek, MD

Title(s)Clinical Assistant Professor of Obstetrics & Gynecology (Part-Time)
SchoolKeck School of Medicine of Usc
AddressIRD 220 2020 Zonal Ave
Off Campus
Los Angeles CA 90033
Phone+1 323 226 2534
vCardDownload vCard
    Other Positions
    Title(s)Director, HIV Services


    Collapse Overview 
    Collapse Overview
    Dr. Stek completed a residency in Obstetrics and Gynecology and a fellowship in maternal-fetal medicine (MFM). Her research and clinical interests are primarily in the field of HIV in pregnancy and HIV in women. She has been conducting clinical research in these areas since starting her MFM Fellowship. Dr. Stek has been active in the Pediatric AIDS Clinical Trials Group for over 12 years, where she serves on the Perinatal RAC, the Obstetrics Subcommittee and the AACTG Womens Health Committee. She is a member of eight PACTG and AACTG protocol teams and is co-chair and vice-chair of several protocols. She is also a member of the local WIHS team.

    Dr. Steks current research, both in the multicenter research organizations and in the MCA Centers own projects, focuses on the use of antiretroviral medications in pregnancy. Dr. Stek, in collaboration with PACTG pharmacologists in Boston, San Diego, and San Francisco, and locally with Dr. Michael Neely and the USC School of Pharmacy, is studying the pharmacokinetics, and safety and efficacy (collaborating with PACTG, AACTG, and MCA internists and pediatricians) of the medications used to prevent perinatal HIV transmission and for maternal health. Together with a pathologist at Baylor University, she is studying placental pathology in women using antiretrovirals during pregnancy. She collaborated with the USC pathology/lo aboratory medicine department and MCA pediatricians in designing and implementing a rapid HIV testing program for women in labor, and is currently evaluating this program with the USC pathology/laboratory medicine department and an MCA epidemiologist. Other collaborative research projects in the PACTG and AACTG include a comprehensive project to collect data on HIV-infected pregnancies, an evaluation of postpartum virologic and immunologic changes, and a trial of a therapeutic HPV vaccine in HIV-positive adolescents. In addition to these research activities, Dr. Stek provides clinical care for MCAs pregnant patients, and teaches at Womens and Childrens Hospital, USC Keck School of Medicine, and occasionally at USC main campus, as well as outside the university both in the local community and outside of Los Angeles.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID-19: Results from IMPAACT 2032. J Infect Dis. 2024 Jun 05. Brooks KM, Baltrusaitis K, Clarke DF, Nachman S, Jao J, Purswani MU, Agwu A, Beneri C, Deville JG, Powis KM, Stek AM, Eke AC, Shapiro DE, Capparelli E, Greene E, George K, Yin DE, Jean-Philippe P, Chakhtoura N, Bone F, Bacon K, Johnston B, Reding C, Kersey K, Humeniuk R, Best BM, Mirochnick M, Momper JD. PMID: 38839047.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    2. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Antimicrob Agents Chemother. 2023 11 15; 67(11):e0073723. Van Schalkwyk M, Bekker A, Decloedt E, Wang J, Theron GB, Cotton MF, Eke AC, Cressey TR, Shapiro DE, Bacon K, Knowles K, George K, Browning R, Chakhtoura N, Rungruengthanakit K, Wiesner L, Capparelli EV, Stek AM, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 37882552; PMCID: PMC10648924.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. "We Are Not Different than Others": A Qualitative Study of the Lived Experience of Hispanic Adolescents and Young Adults Living with Perinatally Acquired HIV. Int J Environ Res Public Health. 2023 02 08; 20(4). Fair C, Fraser L, Zendt M, Santana-Garces M, Homans J, Stek A, Operskalski E. PMID: 36833690; PMCID: PMC9957359.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy. Arch Gynecol Obstet. 2023 12; 308(6):1749-1754. Mazza GR, Solorio C, Stek AM, Kalayjian LA, Wilson ML, Gordon BJ. PMID: 36495328.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. J Acquir Immune Defic Syndr. 2022 12 01; 91(4):403-409. Coutinho CM, Warshaw MG, Duarte G, Stek A, Violari A, Hofer CB, Deville JG, Ngocho JS, Pilotto JH, Correa MD, Shapiro DE, Fuller TL, Chakhtoura N, Mirochnick M, João EC. PMID: 36049477; PMCID: PMC9613542.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. J Acquir Immune Defic Syndr. 2022 07 01; 90(3):343-350. Brooks KM, Pinilla M, Stek AM, Shapiro DE, Barr E, Febo IL, Paul ME, Deville JG, George K, Knowles K, Rungruengthanakit K, Browning R, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 35195573; PMCID: PMC9203910.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. The Obstetrical Care and Delivery Experience of Women with Epilepsy in the MONEAD Study. Am J Perinatol. 2024 05; 41(7):935-943. McElrath TF, Druzin M, Van Marter LJ, May RC, Brown C, Stek A, Grobman W, Dolan M, Chang P, Flood-Schaffer K, Parker L, Meador KJ, Pennell PB, MONEAD Investigator Group. PMID: 35253116.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):303-309. Momper JD, Wang J, Stek A, Shapiro DE, Powis KM, Paul ME, Badell ML, Browning R, Chakhtoura N, Denson K, Rungruengthanakit K, George K, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 34732682; PMCID: PMC8837686.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    9. Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States. Clin Infect Dis. 2021 09 15; 73(6):969-978. Venkatesh KK, Morrison L, Tuomala RE, Stek A, Read JS, Shapiro DE, Livingston EG. PMID: 33768226; PMCID: PMC8442770.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    10. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception. 2022 01; 105:67-74. Kreitchmann R, Stek A, Best BM, Capparelli E, Wang J, Shapiro D, Chakhtoura N, Mirochnick M, Eke AC, IMPAACT P1026s protocol team. PMID: 34407424; PMCID: PMC8678338.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy. J Clin Pharm Ther. 2021 Oct; 46(5):1459-1464. Mulligan N, Salama E, Momper JD, Capparelli EV, Stek A, Chakhtoura N, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 34254323; PMCID: PMC8448937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021 07 01; 35(8):1191-1199. Momper JD, Wang J, Stek A, Shapiro DE, Scott GB, Paul ME, Febo IL, Burchett S, Smith E, Chakhtoura N, Denson K, Rungruengthanakit K, George K, Yang DZ, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 34076612; PMCID: PMC8173003.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    13. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021 03 01; 35(3):407-417. Brooks KM, Momper JD, Pinilla M, Stek AM, Barr E, Weinberg A, Deville JG, Febo IL, Cielo M, George K, Denson K, Rungruengthanakit K, Shapiro DE, Smith E, Chakhtoura N, Rooney JF, Haubrich R, Espina R, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 33252495; PMCID: PMC8238253.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate. Antimicrob Agents Chemother. 2021 02 17; 65(3). Eke AC, Shoji K, Best BM, Momper JD, Stek AM, Cressey TR, Mirochnick M, Capparelli EV. PMID: 33318014; PMCID: PMC8092509.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    15. Darunavir Pharmacokinetics With an Increased Dose During Pregnancy. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):373-380. Eke AC, Stek AM, Wang J, Kreitchmann R, Shapiro DE, Smith E, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. PMID: 31923087; PMCID: PMC7258985.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    16. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy. Antimicrob Agents Chemother. 2020 03 24; 64(4). Eke AC, Wang J, Amin K, Shapiro DE, Stek A, Smith E, Chakhtoura N, Basar M, George K, Knapp KM, João EC, Rungruengthanakit K, Capparelli E, Burchett S, Mirochnick M, Best BM, P1026s Protocol Team. PMID: 32015036; PMCID: PMC7179299.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    17. Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV. PLoS One. 2020; 15(2):e0228900. Bearden A, Van Winden K, Frederick T, Kono N, Operskalski E, Pandian R, Barton L, Stek A, Kovacs A. PMID: 32053638; PMCID: PMC7018030.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    18. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):72-80. Hoffman RM, Warshaw MG, Amico KR, Pilotto J, Masheto G, Achalapong J, Machado E, Chokephaibulkit K, Duarte G, João E, Graham KK, Knapp KM, Stek AM, Scott GB, Coletti A, Loftis AJ, Chakhtoura N, Currier JS, PROMISE 1077HS Team. PMID: 31651545; PMCID: PMC6898779.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period. Am J Perinatol. 2020 12; 37(14):1446-1454. Van Winden KR, Bearden A, Kono N, Frederick T, Operskalski E, Stek A, Pandian R, Barton L, Kovacs A. PMID: 31365935; PMCID: PMC6992493.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Efavirenz pharmacokinetics during pregnancy and infant washout. Antivir Ther. 2019; 24(2):95-103. Kreitchmann R, Schalkwijk S, Best B, Wang J, Colbers A, Stek A, Shapiro D, Cressey T, Mirochnick M, Burger D. PMID: 30530925; PMCID: PMC6642905.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV. AIDS. 2018 11 13; 32(17):2507-2516. Momper JD, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Badell ML, Acosta EP, Purswani M, Smith E, Chakhtoura N, Park K, Burchett S, Shapiro DE, Mirochnick M, IMPAACT P1026s Protocol Team. PMID: 30134297; PMCID: PMC6209536.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    22. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. J Clin Pharmacol. 2019 03; 59(3):386-393. Eke AC, McCormack SA, Best BM, Stek AM, Wang J, Kreitchmann R, Shapiro D, Smith E, Mofenson LM, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol Team. PMID: 30358179; PMCID: PMC6368469.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    23. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):308-313. Eke AC, Chakhtoura N, Kashuba A, Best BM, Sykes C, Wang J, Stek AM, Smith E, Calabrese S, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol Team. PMID: 29528944; PMCID: PMC6002878.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States. Obstet Gynecol. 2018 05; 131(5):879-890. Venkatesh KK, Morrison L, Livingston EG, Stek A, Read JS, Shapiro DE, Tuomala RE. PMID: 29630021; PMCID: PMC6075712.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    25. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS. 2018 03 27; 32(6):729-737. Mulligan N, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Buschur SL, Acosta EP, Smith E, Chakhtoura N, Burchett S, Mirochnick M, IMPAACT P1026s Protocol Team. PMID: 29369162; PMCID: PMC5854536.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsCTClinical Trials
    26. Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus. Obstet Gynecol. 2017 04; 129(4):621-628. Scott GB, Brogly SB, Muenz D, Stek AM, Read JS, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team. PMID: 28277349; PMCID: PMC6122962.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    27. Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):74-82. Livingston EG, Huo Y, Patel K, Tuomala RE, Scott GB, Stek A, P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group. PMID: 27082506; PMCID: PMC4981552.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    28. Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Front Pharmacol. 2016; 7:239. Mulligan N, Schalkwijk S, Best BM, Colbers A, Wang J, Capparelli EV, Moltó J, Stek AM, Taylor G, Smith E, Hidalgo Tenorio C, Chakhtoura N, van Kasteren M, Fletcher CV, Mirochnick M, Burger D. PMID: 27540363; PMCID: PMC4972814.
      View in: PubMed   Mentions: 8  
    29. Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):289-96. Tran AH, Best BM, Stek A, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, George K, Cressey TR, Chakhtoura N, Smith E, Shapiro DE, Mirochnick M, IMPAACT P1026s Protocol Team. PMID: 26918544; PMCID: PMC4911231.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    30. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):33-41. Stek A, Best BM, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, Cressey TR, Mofenson LM, Smith E, Shapiro D, Mirochnick M. PMID: 25950206; PMCID: PMC4579345.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    31. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women. Clin Infect Dis. 2015 Nov 15; 61(10):1582-9. Colbers A, Best B, Schalkwijk S, Wang J, Stek A, Hidalgo Tenorio C, Hawkins D, Taylor G, Kreitchmann R, Burchett S, Haberl A, Kabeya K, van Kasteren M, Smith E, Capparelli E, Burger D, Mirochnick M, PANNA Network and the IMPAACT 1026 Study Team. PMID: 26202768; PMCID: PMC4614410.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    32. PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150. Jacobs J AIDS HIV. 2015; 1(1). Sha BE, Tierney C, Sun X, Stek A, Cohn SE, Coombs RW, Bastow B, Aweeka FT, AIDS Clinical Trials Group (ACTG) 5153s Team. PMID: 26878071; PMCID: PMC4749161.
      View in: PubMed   Mentions: 4  
    33. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015 Sep; 16(8):502-11. Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M, International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) P1026s Team. PMID: 25959631; PMCID: PMC4862736.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    34. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med. 2015 Jan 20; 162(2):90-9. Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R. PMID: 25599347; PMCID: PMC4299931.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsPHPublic Health
    35. Raltegravir pharmacokinetics during pregnancy. J Acquir Immune Defic Syndr. 2014 Dec 01; 67(4):375-81. Watts DH, Stek A, Best BM, Wang J, Capparelli EV, Cressey TR, Aweeka F, Lizak P, Kreitchmann R, Burchett SK, Shapiro DE, Hawkins E, Smith E, Mirochnick M, IMPAACT 1026s study team. PMID: 25162818; PMCID: PMC4213295.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    36. Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Med. 2015 Mar; 16(3):176-83. Aweeka FT, Hu C, Huang L, Best BM, Stek A, Lizak P, Burchett SK, Read JS, Watts H, Mirochnick M, Capparelli EV, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Tea. PMID: 25407158; PMCID: PMC4320673.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    37. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception. Eur J Contracept Reprod Health Care. 2015 Apr; 20(2):149-53. Atrio J, Stek A, Vora H, Sanchez-Keeland L, Zannat F, Natavio M. PMID: 25285572; PMCID: PMC4655593.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    38. Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy. J Antimicrob Chemother. 2015 Jan; 70(1):217-24. Cressey TR, Urien S, Capparelli EV, Best BM, Buranabanjasatean S, Limtrakul A, Rawangban B, Sabsanong P, Treluyer JM, Jourdain G, Stek A, Lallemant M, Mirochnick M. PMID: 25261418; PMCID: PMC4267507.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    39. Reduced indinavir exposure during pregnancy. Br J Clin Pharmacol. 2013 Sep; 76(3):475-83. Cressey TR, Best BM, Achalapong J, Stek A, Wang J, Chotivanich N, Yuthavisuthi P, Suriyachai P, Prommas S, Shapiro DE, Watts DH, Smith E, Capparelli E, Kreitchmann R, Mirochnick M, IMPAACT P1026s team. PMID: 23305215; PMCID: PMC3769674.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    40. Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy. J Acquir Immune Defic Syndr. 2013 May 01; 63(1):59-66. Kreitchmann R, Best BM, Wang J, Stek A, Caparelli E, Watts DH, Smith E, Shapiro DE, Rossi S, Burchett SK, Hawkins E, Byroads M, Cressey TR, Mirochnick M. PMID: 23392467; PMCID: PMC3625451.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    41. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012 Sep; 55(6):877-84. Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A. PMID: 22675157.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsPHPublic Health
    42. Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. J Acquir Immune Defic Syndr. 2012 Mar 01; 59(3):245-52. Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M, IMPAACT P1026s Team. PMID: 22083071; PMCID: PMC3288559.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    43. Effect of pregnancy on emtricitabine pharmacokinetics. HIV Med. 2012 Apr; 13(4):226-35. Stek AM, Best BM, Luo W, Capparelli E, Burchett S, Hu C, Li H, Read JS, Jennings A, Barr E, Smith E, Rossi SS, Mirochnick M. PMID: 22129166; PMCID: PMC3342997.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    44. Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study. BMC Infect Dis. 2011 Sep 30; 11:263. Walter J, Fraga L, Orin MJ, Decker WD, Gipps T, Stek A, Aldrovandi GM. PMID: 21961998; PMCID: PMC3190379.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr. 2011 Apr 15; 56(5):412-9. Mirochnick M, Best BM, Stek AM, Capparelli EV, Hu C, Burchett SK, Rossi SS, Hawkins E, Basar M, Smith E, Read JS, IMPAACT 1026s Study Team. PMID: 21283017; PMCID: PMC3125419.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    46. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23. Sha BE, Tierney C, Cohn SE, Sun X, Coombs RW, Frenkel LM, Kalams SA, Aweeka FT, Bastow B, Bardeguez A, Kmack A, Stek A, Aids Clinical Trials Group ACTG A5150 Team. PMID: 21388937; PMCID: PMC3227722.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    47. Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):335-343. Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, Bardeguez A, Stek A, Read JS, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) Protocol 1025 Study. PMID: 20664394; PMCID: PMC2964131.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    48. Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. J Acquir Immune Defic Syndr. 2010 Aug; 54(4):381-8. Best BM, Stek AM, Mirochnick M, Hu C, Li H, Burchett SK, Rossi SS, Smith E, Read JS, Capparelli EV, International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s Study Team. PMID: 20632458; PMCID: PMC3265163.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    49. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis. 2010 Apr 01; 201(7):1035-44. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, Tuomala RE, P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. PMID: 20196654; PMCID: PMC2946359.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    50. Lopinavir protein binding in HIV-1-infected pregnant women. HIV Med. 2010 Apr; 11(4):232-8. Aweeka FT, Stek A, Best BM, Hu C, Holland D, Hermes A, Burchett SK, Read J, Mirochnick M, Capparelli EV, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Tea. PMID: 20002783; PMCID: PMC2874627.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    51. Antiretroviral medications during pregnancy for therapy or prophylaxis. Curr HIV/AIDS Rep. 2009 May; 6(2):68-76. Stek AM. PMID: 19358777.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    52. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS. 2009 Feb; 23(2):101-8. Kapetanovic S, Christensen S, Karim R, Lin F, Mack WJ, Operskalski E, Frederick T, Spencer L, Stek A, Kramer F, Kovacs A. PMID: 19196032; PMCID: PMC2856494.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    53. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum. HIV Clin Trials. 2009 Jan-Feb; 10(1):41-7. Bennetto-Hood C, Bryson YJ, Stek A, King JR, Mirochnick M, Acosta EP. PMID: 19362995.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    54. Lopinavir exposure with an increased dose during pregnancy. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):485-91. Mirochnick M, Best BM, Stek AM, Capparelli E, Hu C, Burchett SK, Holland DT, Smith E, Gaddipati S, Read JS, PACTG 1026s Study Team. PMID: 18989231; PMCID: PMC3912695.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    55. Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. HIV Med. 2008 Nov; 9(10):875-82. Read JS, Best BM, Stek AM, Hu C, Capparelli EV, Holland DT, Burchett SK, Smith ME, Sheeran EC, Shearer WT, Febo I, Mirochnick M. PMID: 18795962; PMCID: PMC2732353.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    56. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr. 2008 Aug 01; 48(4):408-17. Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, Stek A, Buschur S, Cotter A, Bettica L, Read JS, PACTG 1025 Protocol Team. PMID: 18614923; PMCID: PMC2764488.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    57. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Med. 2008 Apr; 9(4):214-20. Capparelli EV, Aweeka F, Hitti J, Stek A, Hu C, Burchett SK, Best B, Smith E, Read JS, Watts H, Nachman S, Thorpe EM, Spector SA, Jimenez E, Shearer WT, Foca M, Mirochnick M, PACTG 1026S Study Team, PACTG P1022 Study Team. PMID: 18366444; PMCID: PMC2755564.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    58. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials. 2008 Mar-Apr; 9(2):115-25. Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E, PACTG 353 Team. PMID: 18474496; PMCID: PMC4043374.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    59. Antiretroviral treatment in pregnancy. Curr Opin HIV AIDS. 2008 Mar; 3(2):155-60. Stek AM. PMID: 19372959.
      View in: PubMed   Mentions: 3     Fields:    
    60. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception. 2008 Feb; 77(2):84-90. Watts DH, Park JG, Cohn SE, Yu S, Hitti J, Stek A, Clax PA, Muderspach L, Lertora JJ. PMID: 18226670; PMCID: PMC2424313.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    61. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis. 2007 Oct; 11(4):240-50. Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Mph LC, Moxley MD, Weber KM, Watts DH. PMID: 17917568.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. Am J Obstet Gynecol. 2007 Apr; 196(4):331.e1-7. Hitti J, Andersen J, McComsey G, Liu T, Melvin A, Smith L, Stek A, Aberg J, Hull A, Alston-Smith B, Watts DH, Livingston E, AIDS Clinical Trials Group 5084 Study Team. PMID: 17403409.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    63. Participation of HIV-infected pregnant women in research in the United States. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):51-3. Brogly S, Read JS, Shapiro D, Stek A, Tuomala R. PMID: 17263632.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions. Clin Pharmacol Ther. 2007 Feb; 81(2):222-7. Cohn SE, Park JG, Watts DH, Stek A, Hitti J, Clax PA, Yu S, Lertora JJ, ACTG A5093 Protocol Team. PMID: 17192768.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    65. Reduced lopinavir exposure during pregnancy. AIDS. 2006 Oct 03; 20(15):1931-9. Stek AM, Mirochnick M, Capparelli E, Best BM, Hu C, Burchett SK, Elgie C, Holland DT, Smith E, Tuomala R, Cotter A, Read JS. PMID: 16988514.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    66. Impact of pregnancy on abacavir pharmacokinetics. AIDS. 2006 Feb 28; 20(4):553-60. Best BM, Mirochnick M, Capparelli EV, Stek A, Burchett SK, Holland DT, Read JS, Smith E, Hu C, Spector SA, Connor JD, PACTG P1026s Study Team. PMID: 16470119.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    67. Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. J Acquir Immune Defic Syndr. 2005 Jun 01; 39(2):189-94. Mirochnick M, Stek A, Acevedo M, Keller M, Holland D, Capparelli E, Connor J, Huang S, Hughes M, Watts H, Mofenson L, Bryson Y. PMID: 15905735.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    68. HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women. Addiction. 2005 May; 100(5):626-35. Nikolopoulou GB, Nowicki MJ, Du W, Homans J, Stek A, Kramer F, Kovacs A. PMID: 15847620; PMCID: PMC3118993.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    69. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci. 2004 Sep 15; 224(1-2):69-76. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. PMID: 15450773.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    70. Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022. J Acquir Immune Defic Syndr. 2004 Jul 01; 36(3):772-6. Hitti J, Frenkel LM, Stek AM, Nachman SA, Baker D, Gonzalez-Garcia A, Provisor A, Thorpe EM, Paul ME, Foca M, Gandia J, Huang S, Wei LJ, Stevens LM, Watts DH, McNamara J, PACTG 1022 Study Team. PMID: 15213559.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    71. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2004 Feb; 48(2):430-6. Acosta EP, Bardeguez A, Zorrilla CD, Van Dyke R, Hughes MD, Huang S, Pompeo L, Stek AM, Pitt J, Watts DH, Smith E, Jiménez E, Mofenson L, Pediatric AIDS Clinical Trials Group 386 Protocol Team, . PMID: 14742191; PMCID: PMC321538.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    72. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS. 2004 Jan 23; 18(2):281-6. Massad LS, Springer G, Jacobson L, Watts H, Anastos K, Korn A, Cejtin H, Stek A, Young M, Schmidt J, Minkoff H. PMID: 15075546.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    73. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002 Jun 13; 346(24):1863-70. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M. PMID: 12063370.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    74. Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients. J Matern Fetal Med. 2001 Jun; 10(3):203-8. Samadi R, Stek A, Greenspoon JS. PMID: 11444791.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    75. The relationship of pregnancy to the use of highly active antiretroviral therapy. Am J Obstet Gynecol. 2001 May; 184(6):1221-7. Minkoff H, Ahdieh L, Watts H, Greenblatt RM, Schmidt J, Schneider M, Stek A. PMID: 11349192.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    76. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers. Ann N Y Acad Sci. 2000 Nov; 918:262-8. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Baker R, Stek AM, Khoury MM, Poirier MC. PMID: 11131712.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    77. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS. 2000 Jul 07; 14(10):1389-99. Lambert JS, Watts DH, Mofenson L, Stiehm ER, Harris DR, Bethel J, Whitehouse J, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H, van Dyke R, Maupin R, Silio M, Fowler MG. PMID: 10930154.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    78. Mode of delivery and the risk of vertical transmission of HIV-1. N Engl J Med. 1999 Jul 15; 341(3):205-6; author reply 206-7. Beckerman KP, Morris AB, Stek A. PMID: 10409037.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    79. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC. PMID: 10371172.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    80. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J Infect Dis. 1999 Mar; 179(3):567-75. Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H. PMID: 9952362.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    81. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg. 1998 Apr; 58(4):495-500. Sorvillo F, Kovacs A, Kerndt P, Stek A, Muderspach L, Sanchez-Keeland L. PMID: 9574798.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    82. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group. J Infect Dis. 1997 Feb; 175(2):283-91. Lambert JS, Mofenson LM, Fletcher CV, Moye J, Stiehm ER, Meyer WA, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A. PMID: 9203648.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    83. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol. 1995 Nov; 173(5):1592-8. Stek AM, Baker RS, Fisher BK, Lang U, Clark KE. PMID: 7503206.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    84. Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep. Am J Obstet Gynecol. 1993 Oct; 169(4):888-97. Stek AM, Fisher BK, Baker RS, Lang U, Tseng CY, Clark KE. PMID: 8238145.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    Alice's Networks
    Concepts (272)
    Derived automatically from this person's publications.
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _